Developing Innovative Therapeutics for Ocular Diseases Global leading candidate in Phase 2b for the treatment of adenoviral conjunctivitis. Research & Development Enhancing Lives Through Better Vision Okogen, founded in 2015, is a clinical stage ophthalmic specialty biotechnology company. We are exclusively focused on developing the leading treatment of adenoviral conjunctivitis. With acute conjunctivitis representing 1% […]
Location: United States, California, San Diego
Employees: 1-10
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Brandon Ca... | brandoncap... |
Mentions in press and media 1
| Date | Title | Description |
| - | Okogen | “Innovating the Pink Eye Treatment Landscape Leading candidate in Phase 2B for the treatment of Acute Infectious Conjunctivitis. Research & Development Enhancing Lives Through Better Vision Okogen is a clinical stage ophthalmic pharmace... |